Salesi et al. (2021) investigated the occurrence of COVID-19 in 254 rheumatoid arthritis or seronegative spondyloarthropathy patients who were prescribed TNF-α blockers prior to the contraction of COVID-19 [93]. This evidence concerns the gene TNF and rheumatoid arthritis.